<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00499304</url>
  </required_header>
  <id_info>
    <org_study_id>NL13873.09406</org_study_id>
    <nct_id>NCT00499304</nct_id>
  </id_info>
  <brief_title>Forced Oscillation Technique (FOT) and Expiratory Flow Limitation (EFL)</brief_title>
  <official_title>Diagnosing Expiratory Flow Limitation in COPD Patients With the Forced Oscillation Technique Using Linear Regression in the Time Frequency Domain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical Center Alkmaar</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical Center Alkmaar</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to distinguish COPD patients with expiratory flow limitation in body&#xD;
      plethysmography (open loop) from the patients without expiratory flow limitation in body&#xD;
      plethysmography (closed loop) with the obtained FOT parameters.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In daily practice the expiratory flow limitation is measured by body plethysmography. An open&#xD;
      loop in body plethysmography shows expiratory flow limitation in COPD patients. But body&#xD;
      plethysmography requires that the patient quietly sits in a closed box and is not able to&#xD;
      follow changes breath by breath. The goal of this study is to validate the Forced oscillation&#xD;
      technique (FOT) for measuring expiratory flow limitation in COPD patients.30 COPD patients&#xD;
      with an open loop in body plethysmography are compared to 30 COPD patients with a closed&#xD;
      loop. The methods used in this study are the maximal overlap discrete short time Fourier&#xD;
      transform (MODFT) combined with a total least squares analysis. It is hypothesized that the&#xD;
      obtained FOT parameters are able to distinguish the patients with expiratory flow limitation&#xD;
      in body plethysmography from the patients without expiratory flow limitation in body&#xD;
      plethysmography.Secondary study questions are: 1) to what extend are the FOT parameters&#xD;
      distorted by breathing artifacts and measurement noise. 2)What changes can be detected by FOT&#xD;
      in expiratory flow limitation after administration of salbutamol.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2006</start_date>
  <completion_date type="Actual">April 2008</completion_date>
  <primary_completion_date type="Actual">April 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">60</enrollment>
  <condition>COPD</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Stable GOLD 2-4 COPD patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Presenting to the outpatient clinic&#xD;
&#xD;
          -  Age 50-80 years&#xD;
&#xD;
          -  Diagnosed with COPD according to the standard criteria&#xD;
&#xD;
          -  Gold Stage II to IV COPD&#xD;
&#xD;
          -  Current or ex-smokers (at least 10 PY)&#xD;
&#xD;
          -  Stable disease (No current exacerbation or exacerbation during the 4 weeks previous to&#xD;
             the inclusion)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of exacerbation of COPD in the preceding month&#xD;
&#xD;
          -  Upper airway obstruction&#xD;
&#xD;
          -  Allergic Asthma&#xD;
&#xD;
          -  OSAS (obstructive sleep apnea syndrome)&#xD;
&#xD;
          -  Extreme obesity (BMI&gt;35)&#xD;
&#xD;
          -  Clinically manifest cardiac disease (for example clinically relevant congestive heart&#xD;
             failure, unstable angina pectoris)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dewi Tjiong, drs</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Center Alkmaar</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical Center Alkmaar</name>
      <address>
        <city>Alkmaar</city>
        <zip>1815JD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>June 2008</verification_date>
  <study_first_submitted>July 10, 2007</study_first_submitted>
  <study_first_submitted_qc>July 10, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 11, 2007</study_first_posted>
  <last_update_submitted>June 5, 2008</last_update_submitted>
  <last_update_submitted_qc>June 5, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 6, 2008</last_update_posted>
  <keyword>Forced oscillation Technique (FOT)</keyword>
  <keyword>Expiratory flow limitation (EFL)</keyword>
  <keyword>Breathing artifacts</keyword>
  <keyword>COPD</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

